List view / Grid view

AstraZeneca

Filter the results

 

article

Mass spectrometry imaging in drug discovery

11 September 2017 | By ,

Mass spectrometry imaging allows direct measurement of the molecular composition of a sample. It can be used to image the spatial distribution of exogenous drugs and endogenous metabolites simultaneously over the surface of tissue sections or small biopsy, allowing new insights into both compound efficacy and safety during drug discovery.

news

Lorenz Mayr joins Drug Discovery 2017 speaker lineup

31 January 2017 | By

Lorenz Mayr, esteemed Vice President and Global Head of Biological Reagents and Assay Development at AstraZeneca will be joining the expert speaker lineup for the launch conference on Drug Discovery. The event takes place on 27 and 28 April 2017 in London.